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Myosin heavy chain (MHC) is a large, multidomain protein important for both cellular structure
and contraction. To examine the functional role of two C-terminal domains, the end of the
coiled-coil rod and the nonhelical tailpiece, we have generated constructs in which residues within
these domains are removed or mutated, and examined their behavior in Caenorhabditis elegans
striated muscle. Genetic tests demonstrate that MHC lacking only tailpiece residues is competent
to support the timely onset of embryonic contractions, and therefore viability, in animals lacking
full-length MHC. Antibody staining experiments show that this truncated molecule localizes as
wild type in early stages of development, but may be defective in processes important for thick
filament organization later in embryogenesis. Ultrastructural analysis reveals thick filaments of
normal morphology in disorganized arrangement, as well as occasional abnormal assemblages. In
contrast, molecules in which the four terminal residues of the coiled coil are absent or mutated fail
to rescue animals lacking endogenous MHC. Loss of these four residues is associated with delayed
protein localization and delayed contractile function during early embryogenesis. Our results
suggest that these two MHC domains, the rod and the tailpiece, are required for distinct steps
during muscle development.
INTRODUCTION
The mechanism by which the proteins of the striated muscle
thick filament are organized into the highly ordered contrac-
tile apparatus is an important unresolved question in the
biology of the muscle cell. A key aspect of the process, how
a cell specifies where and when to build a thick filament, is
poorly understood. Control of filament placement presum-
ably involves regulation of the distribution and activity of at
least some of the individual protein components found
within the thick filament. In invertebrates, the major struc-
tural proteins of the thick filament are myosin heavy chain
(MHC) and paramyosin, which is homologous to the C-
terminal two-thirds of the MHC coiled-coil domain or “rod”
(Kagawa et al., 1989). In this article, we investigate the role of
two MHC domains, the C-terminal rod and the tailpiece, in
MHC localization and function in Caenorhabditis elegans stri-
ated muscle.
The rod has long been recognized as the filament-forming
domain of the MHC molecule (for review, see Squire, 1981).
Interaction of rod residues is thought to play a large part in
driving filament assembly and specifying filament structure
in striated muscle. A potential mechanism for temporal and
spatial control of filament assembly is regulation of the
accessibility or activity of the rod residues required for
filament initiation. In smooth muscle, such regulation has
been proposed to occur through the action of a C-terminal
tailpiece domain: a small, nonhelical region that contains
phosphorylation sites. Phosphorylation of the tailpiece pro-
motes the formation of a folded, assembly-incompetent con-
fomer (Castellani and Cohen, 1987). In addition to regulation
of assembly competence, the smooth muscle MHC tailpiece
may play a structural role, influencing molecular packing
within the filament (Rovner et al., 2002).
Tailpiece sequences are often associated with nonmuscle
myosins that form dynamic structures. Studies using pri-
marily biochemical techniques suggest that the tailpiece may
have different functions in nonmuscle myosins and may
even serve more than one role in a given molecule. Like
smooth muscle myosin, the tailpiece domain of nonmuscle
myosins has been implicated in filament assembly and struc-
ture. For example, in human nonmuscle myosin II, tailpiece
phosphorylation acts to decrease assembly of rod fragments
in vitro (Murakami et al., 1998). In Acanthamoeba, the tail-
piece has been proposed to mediate the initial association of
assembling myosin II molecules (Sinard et al., 1989), thereby
driving assembly and specifying minifilament structure.
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There are contradictory data as to whether phosphorylation
regulates assembly of Acanthamoeba myosin into filaments
(Collins et al., 1982; Sinard and Pollard, 1989). Phosphoryla-
tion of the tailpiece has also been proposed as a mechanism
for regulating activity of the MHC motor domain once fila-
ments are formed (Sathyamoorthy et al., 1990).
A tailpiece domain is present in the MHC and paramyosin
proteins of C. elegans body-wall muscle. Interestingly, these
homologous sequences are at opposite ends of the two mol-
ecules: the MHC tailpiece is at the extreme C terminus,
whereas the paramyosin “tailpiece” is at the extreme N
terminus. The paramyosin tailpiece is phosphorylated at
multiple sites by an endogenous kinase, and a phosphory-
lation motif (S_S_A) was identified (Schriefer and Water-
ston, 1989). Several copies of this motif are found in the
tailpiece domain of the body-wall MHC isoforms. MHC is
also phosphorylated (Dey et al., 1992), but the location of the
phosphorylated residues is unknown.
The C. elegans body-wall muscle cells provide a system
with well-defined genetics and morphology in which to test
the function of MHC domains (for reviews, see Waterston,
1988; Moerman and Fire, 1997). Two isoforms of MHC
(MHC A and MHC B) assemble upon a core composed of
paramyosin and associated proteins (Deitiker and Epstein,
1993). MHC A, encoded by the myo-3 gene, is present in the
central 1.8-m region of the 10-m-long thick filament. This
region includes the part of the bipolar filament in which
myosin molecules associate in an antiparallel (tail-to-tail)
manner (Miller et al., 1983). Mutations in the myo-3 locus that
eliminate MHC A cause the complete lack of normal thick
filaments, resulting in paralysis and death (Waterston, 1989).
Thus, MHC A is required for an essential aspect of filament
formation. The major isoform, MHC B, is encoded by unc-54
(Epstein et al., 1974) and is present in the filament arms,
where parallel addition occurs. Mutations that eliminate
MHC B reduce the number of thick filaments present. The
resulting filaments can be of normal length, and they contain
MHC A along their entire length (Epstein et al., 1986). In-
creasing the expression of the minor isoform, MHC A, can
restore an unc-54 (MHC B-deficient) animal to near wild
type (Fire and Waterston, 1989). Thus, in addition to being
required to initiate the filament center, MHC A can add in
parallel to form the filament arms.
In this article, we use the advanced molecular genetics of
C. elegans to examine the function of the nonhelical tailpiece
and the C-terminal rod. Performing these experiments in
vivo allows the assessment of MHC function in the context
of the muscle cell, with its full complement of potential
interacting proteins, including endogenous kinases. Our re-
sults demonstrate that very small perturbations of the coiled
coil have dramatic effects on early myosin localization and
the onset of contractile function. In contrast, removal of
tailpiece residues has no discernible effect on these early
events of protein localization and filament formation. In-
stead, defects observed during later stages of embryogenesis
and in adults suggest that the tailpiece domain may be
required to establish or maintain proper filament position
within the sarcomere. These observations suggest that the
functions of the rod and the tailpiece are distinct, and are




MHC A construct, pUCAA plasmid: RW3680 unc-54(e190); stEx79.
RW3825 unc-54(e190); myo-3(st386); stEx79. RW3838 myo-3(st386);
stEx79. RW3681 unc-54(e190); stEx80. RW3685 myo-3(st386); stEx80.
RW3826 unc-54(e190); myo-3(st386); stEx80.
30, pRA7: RW3896 unc-54(e190); myo-3(st386); stEx148. RW3897
unc-54(e190); myo-3(st386); stEx149. RW3873 unc-54(e190); stEx148.
RW3874 unc-54(e190); stEx149. RW3883 myo-3(st386); stEx149.
RW3884 myo-3(st386); stEx148. RW3875 unc-54(e190); stEx150.
RW3889 myo-3(st386); stEx150.
BHtag30, pPP3: RW3885 unc-54(e190); stEx152. RW3905 myo-
3(st386); stEx152. RW3906 unc-54(e190); myo-3(st386); stEx152.
RW3907 myo-3(st386); stEx153. RW3908 unc-54(e190); myo-3(st386);
stEx153. RW3886 unc-54(e190); stEx153. RW3909 myo-3(st386);
stEx154. RW3887 unc-54(e190); stEx154.
34, pRA4: RW3829 unc-54(e190); stEx129. RW3867 myo-3(st386);
stEx129. RW3868 unc-54(e190); myo-3(st386)/eDf1; stEx129.
BH34 previously called chimera 6 (Hoppe and Waterston, 1996):
New transgenic lines carrying the rol-6::GFP coinjection marker
were generated for these experiments. RW3824 unc-54(e190);
stEx111. RW3781 myo-3(st386); stEx111. RW3820 unc-54(e190); myo-
3(st386)/eDf1; stEx111. RW3823 unc-54(e190); stEx112. RW3817 unc-
54(e190); myo-3(st386)/eDf1; stEx112. RW3782 myo-3(st386); stEx112.
RW3783 myo-3(st386); stEx113. RW3818 unc-54(e190); stEx113.
RW3819 unc-54(e190); myo-3(st386)/eDf1; stEx113. RW3816 unc-
54(e190); stEx114. RW3784 myo-3(st386); stEx114.
BHtag34, pRA2: RW3828 myo-3(st386); stEx120. RW3830 unc-
54(e190); myo-3(st386)/eDf1; stEx120. RW3833 unc-54(e190); stEx120.
Chimera 3: RW3768 unc-54(e190); stEx55. RW3827 unc-54(e190);
myo-3(st386); stEx55.
Chimera 4.tag: RW3811 unc-54(e190); stEx118. RW3860 unc-
54(e190); myo-3(st386); stEx118
BHtagKIRA: RW3942 unc-54(e190); stEx200; RW3949 myo-
3(st386); stEx200; RW3954 unc-54(e190); myo-3(st386)/eDf1; stEx200
BHtagPIRA: RW3946 unc-54(e190); stEx203. RW3957 myo-3(st386);
stEx203. RW3956 unc-54(e190); myo-3(st386)/eDf1; stEx203. RW3947
unc-54(e190); stEx204. RW3955 myo-3(st386); stEx204. RW3958 unc-
54(e190); myo-3(st386)/eDf1; stEx204.
BHtagPIAA: RW3944 unc-54(e190); stEx201. RW3951 myo-3(st386);
stEx201. RW3952 unc-54(e190); myo-3(st386)/eDf1; stEx201. RW3945
unc-54(e190); stEx202. RW3950 myo-3(st386); stEx202. RW3953 unc-
54(e190); myo-3(st386)/eDf1; stEx202.
DNA Construct
The previously published chimera 6 construct (Hoppe and Water-
ston, 1996) has been renamed BH34. The premature stop codon
resulted from an error introduced during a polymerase chain reac-
tion step used to generate chimera 4, which contains MHC B se-
quences in the tailpiece domain. Therefore, the last amino acid
residue before the stop codon is from MHC B, but the remainder of
the rod residues are from MHC A. The other 34 constructs were
made by moving the sequences encoding the premature stop codon
from BH34 to the myo-3 gene or a hemagglutinin (HA)-tagged
chimeric construct, by using standard cloning techniques and pre-
viously described genomic cassettes (Hoppe and Waterston, 1996).
The addition of the HA epitope tag to the MHC B head has been
described previously (Hoppe and Waterston, 2000). To make the
30 constructs, oligo ACAAGATTCGTGCATaAtaaTCCATG-
GaTCCACCAGATGGTTT and its complement were used with the
Stratagene QuikChange kit to replace S1940 and A1941 codons with
consecutive ochre codons in the 1.4-kb SphI-KpnI subclone encoding
the myo-3 C terminus. The same protocol was used with the following
oligonucleotides to generate the constructs containing mutations
within the C-terminal rod: KIRA, CTGTCAAAGATGCGTAACT-
CAGCTTCgATGGCTCCACCA; PIRA, TCAAAGATGCGTAAC-
ccaATTCGTGCcTCAGCTTCCATGGC; and PIAA, TCAAAGAT-
P.E. Hoppe et al.
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GCGTAACccaATTgccGCcTCAGCTTCCATGGC. Oligonucleotide
bases in lowercase do not match wild-type sequence and include silent
mutations to eliminate hairpins. Fragments generated by polymerase
chain reaction were verified by DNA sequencing. Complete constructs
encoding truncated MHC A or chimeric proteins were made by mov-
ing the mutant subclone as described for 34.
Injections
Transformed lines were generated as described previously (Mello et
al., 1991). A 30:10:1 ratio of Bluescript/pPHgfp-1/myosin (at 200
ng/l in 10 mM Tris, 1 mM EDTA, pH 8) was used to produce
extrachromosomal arrays with low myosin copy number. The coin-
jection marker expresses green fluorescent protein (GFP) in the
hypodermis under the control of the rol-6 promoter (Hoppe and
Waterston, 2000). Arrays were selected for robust expression by
injection into unc-54(e190) animals and screening for restoration of
motility. Arrays with lower expression levels were identified by
poor rescue of unc-54(0), or by injection into myo-3(st386)/eDf1 and
screening rescued myo-3 homozygotes for wild-type muscle struc-
ture by using polarized light microscopy. To test whether a con-
struct could support viability when it is the only myosin heavy
chain expressed, arrays with robust expression were first crossed
into an unc-54(e190); myo-3(st386)/eDf1; stExN background. Animals
were then picked singly to identify any viable double mutant ani-
mals, which do not segregate the recessive larval lethal phenotype
associated with the eDf1 balancer chromosome.
Brood Analysis
Transgenic unc-54(e190); myo-3(st386)/eDf1; stExN hermaphrodites
were picked singly to freshly seeded plates and allowed to lay for
1 d. After an additional day, the transgenic progeny (identified
using a fluorescent dissecting microscope) were sorted and counted.
Arrested animals that showed no GFP signal were picked onto
microscope slides and scored again using a compound fluorescent
microscope. Viable transgenic animals were picked singly to plates,
and their progeny examined to determine parental genotype.
Antibody Staining
Embryos were fixed with paraformaldehyde and methanol and
stained using the methods of Hresko et al. (1994). Adults were
fragmented, fixed with methanol, and stained as described previ-
ously (Francis and Waterston, 1985). Monoclonal antibodies 5–6,
5–8, and 5–14 were gifts of Henry Epstein and Irving Ortiz (Baylor
College of Medicine, Houston, TX). The HA epitope was detected
using the rat monoclonal anti-HA high affinity (Roche Diagnostics,
Indianapolis, IN).
Time-Lapse Recording
Gravid adult hermaphrodites were cut in half with a razor blade in
M9 buffer. The embryos in a small amount of buffer were trans-
ferred to a 2% agarose pad on a microscope slide and covered and
gently flattened with a Vaseline-lined coverslip. The embryos were
videotaped overnight (16 h) using Nomarski optics and then
photographed on a fluorescence microscope to record the presence
of GFP expression in any arrested individuals. The progression of
development up until the twofold stage (designated as 450 min in
Figure 3) was scored by monitoring morphology rather than actual
time elapsed. Subsequent to the twofold stage, elapsed time was
used to determine the point at which movement began. Because
temperature was not strictly controlled, all times are approximate.
The strains carrying genomic mutations were RW3667 myo-3(st386)/
eDf1, CB190 unc-54(e190), and RW3858 unc-54(e190); myo-3(st386)/
eDf1.
Electron Microscopy
Samples were prepared as in Waterston et al. (1977): adult worms
were fixed with 3% glutaraldehyde, 0.1 M sodium phosphate (pH
7.4) at 0°C for 4 h., cut in half, and fixed overnight in the same
solution. After postfixation in 1% osmium tetroxide in 0.1 M sodium
phosphate (pH 7.4) for 1 h at 4°C, the samples were embedded in
agarose, dehydrated, and embedded as described previously (Hall,
1995) using a Pelco eponate 12 kit.
RESULTS
To investigate the possible structural or regulatory roles of
the C-terminal MHC residues in thick filament formation
and function, we generated various mutant constructs con-
taining point mutations or deletions within the tailpiece
and/or C-terminal rod residues. Extrachromosomal arrays
expressing mutant or chimeric protein were isolated (see
MATERIALS AND METHODS) and crossed into various
genetic backgrounds to test their ability to function in dif-
ferent aspects of thick filament formation. Filament initiation
function was assessed by testing for rescue of the lethal
phenotype of myo-3(0) mutations, which eliminate MHC A.
Competence in thick filament elongation and contractile
function was assessed by the ability to restore motility in
unc-54(0) animals, which lack MHC B. Last, constructs were
tested in the double mutant background to determine the
requirement for C-terminal residues in animals that express
no other MHC in their body-wall muscles.
Constructs were made primarily using the myo-3 gene,
which encodes MHC A, the minor isoform that is essential
for thick filament initiation, and therefore for viability (see
INTRODUCTION). All chimeric constructs, made by com-
bining sequences from MHC A and MHC B, contain all or
most of the MHC A rod and are therefore able to supply
MHC A-specific initiation function in a myo-3(0) mutant
(Hoppe and Waterston, 1996). Chimeric and HA-tagged
constructs were included to test the function of different
MHC domains and to allow construct-specific antibody
staining experiments (see below).
Truncated Constructs Define a Four-Amino-Acid
Region of Coiled Coil Required for Viability
The C-termini of the constructs are shown in Figure 1A, and
diagrams of the sequence content of the complete constructs
are shown in Figure 1B. The 30 and BHtag30 (chimeric)
constructs lack all potential phosphorylation motifs, but
based upon paircoil scores (Berger et al., 1995) are likely to
have an intact rod. These constructs were used to examine
the behavior of MHC lacking only the tailpiece domain. The
use of truncations, rather than point mutations, is likely to
produce a loss-of-function phenotype and requires no as-
sumptions as to the precise site or timing of potential phos-
phorylation events. The more severe truncation, present in
all 34 constructs, removes the tailpiece and four residues
within presumptive coiled coil. The 34 constructs were
used to determine the effects of disrupting the extreme C
terminus of the coiled-coil domain. The results of the genetic
tests are shown in Figure 1B. All truncated constructs were
able to produce lines of rescued myo-3(0) homozygous ani-
mals. Similarly, all constructs rescued the paralysis of unc-
54(0) mutants. These genetic tests demonstrate that trun-
cated proteins lacking up to 34 C-terminal residues have
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sufficient function to restore viability and motility in single-
mutant animals lacking either MHC A or MHC B.
To determine whether functional thick filaments could be
formed containing only truncated myosin, we tested the
transgenes for rescue in the double-mutant background unc-
54(0); myo-3(0). MHC A and chimeric constructs that lack all
of the potential phosphorylation motifs (30) rescue the
double mutant animals to viability and are thus competent
to function as the sole myosin heavy chain. Some of the
rescued lines have good motility and egg-laying function,
but do not seem completely wild type in movement. The
observed slowness may be due to a number of factors,
including inappropriate levels of myosin accumulation or a
small impairment in MHC function. However, these results
demonstrate that the nonhelical tailpiece and its candidate
phosphorylation motifs do not play an essential role in thick
filament formation or function.
In contrast, the 34 constructs could not be isolated in the
double-mutant background (Figure 1B). Therefore, the four
residues of predicted coiled coil that are present in 30 but
absent in 34 are essential for some aspect of myosin func-
tion. The two full-length chimeric constructs, chimera 3 and
chimera4.tag, which contain the MHC A rod but have some
MHC B sequences, both rescue the double mutant. Thus, the
MHC A head and tailpiece residues do not have isoform-
specific function that is required for viability. Furthermore,
the presence of the HA tag does not affect rescuing activity.
The Four-Amino-Acid Region KIRA Contains Highly
Conserved Charged Residues
Genetic tests of the truncated constructs 30 and 34 define
an essential region of the MHC A C-terminal coiled coil
containing the residues KIRA. To examine the importance of
these residues in striated muscle of other species, we com-
pared the C-termini of striated muscle myosins from a va-
riety of organisms (Figure 2). The two charged residues
within the four-residue region (lysine and arginine) are
highly conserved, suggesting an important role for this part
of the coiled coil in all striated muscle. In contrast, the length
Figure 1. Truncated constructs de-
fine a small region of predicted coiled
coil that is essential for viability. (A)
Top line shows the N-terminal nonhe-
lical peptide in paramyosin that is
phosphorylated by an endogenous ki-
nase (see INTRODUCTION). The pro-
posed phosphorylation motif S_S_A is
underlined. The C termini of full-
length MHC A (black) and MHC B
(gray) are shown as aligned by the
program Megalign, with the C termini
of mutant and chimeric constructs
shown below. The number of C-termi-
nal residues removed in each con-
struct follows the delta () symbol.
Those residues designated as nonheli-
cal score p 0 in paircoil (Berger et al.,
1995), and those designated as rod
score p  1.0. The 34 constructs con-
tain unc-54 (MHC B) sequences that
result in the presence of a single MHC
B amino acid residue at the C termi-
nus (see MATERIALS AND METH-
ODS). Amino acid residues changed
by missense mutation are marked by a
shaded rectangle. (B) Constructs were
tested for the ability to rescue single
mutant animals lacking one MHC iso-
form, and for the ability to rescue dou-
ble mutant animals lacking both iso-
forms. Schematic drawings of the
myosin constructs (left) show MHC A
residues in black and MHC B residues
in gray. The oval represents the head
domain, the thick line represents the
coiled-coil rod, and the small angled
C-terminal box represents the tail-
piece. BH denotes the presence of the
MHC B head, and the boxed HA label
or “tag” indicates the addition of the
hemagglutinin epitope. Some of the
single mutant data have been pub-
lished (Hoppe and Waterston, 1996).
ND, not done; P, partial rescue.
P.E. Hoppe et al.
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of the potential tailpiece domain, as well as the placement of
possible phosphorylatable residues (serines and threonines)
within this domain, varies among species. Therefore, the
role of the tailpiece, or at least the mechanism of domain
action, does not seem to be broadly conserved. Invertebrate
myosins tend to have a longer tailpiece that contains a
number of phosphorylatable residues. Interestingly, all ver-
tebrate striated-muscle myosins examined contain a phos-
phorylatable residue within the four-amino-acid region of
coiled coil defined by our truncated constructs.
The Four-Amino-Acid Region Is Essential for
Function of Full-Length MHC
Our experiments with truncated constructs indicate that
removal of the tailpiece and four residues of coiled coil
disrupts an essential myosin function, whereas removal of
the tailpiece alone does not. To determine whether the four
coiled-coil residues, KIRA, are essential for MHC function in
molecules that contain an intact tailpiece domain, we gen-
erated three constructs in which either one or both con-
served basic residues (K, R) were altered or deleted (Figure
1A). The BHtagKIRA construct contains an in-frame dele-
tion that removes the four-residue region. The resulting
protein is thus slightly shorter and has a small shift in the
position of the tailpiece relative to the remainder of the
molecule. The other two constructs contain point mutations
that alter the properties of the KIRA region but leave the
overall length of the molecule intact. The BHtagPIRA con-
struct changes K1936 to P, eliminating a positive charge and
prematurely disrupting the coiled coil. The BHtagPIAA con-
struct, containing mutations K1936P and R1938A, eliminates
two positive charges and prematurely disrupts coiled coil.
Genetic tests revealed that the two constructs in which
both basic residues were altered or deleted failed to rescue
double mutant animals (Figure 1B). Thus, mutations within
the four residues of C-terminal coiled coil result in the
disruption of an essential myosin function despite the pres-
ence of an intact tailpiece. The inability of the tailpiece
domain to compensate for disruption of the four-residue
region of coiled coil suggests that the two domains play
distinct roles in thick filament formation or function.
The BHtagPIRA construct, in which the K1936P change
prematurely disrupts coiled coil and removes one of the
conserved basic residues, exhibits partial function in vivo.
Most double mutant animals expressing only BHtagPIRA
die (Table 1). However, some animals of this genotype sur-
vive and reproduce, although most of their transgenic prog-
eny die. These data suggest that the mutational changes in
BHtagPIRA reduce protein function to a level near the
threshold of activity required for survival. Again, the tail-
piece domain in this full-length construct cannot compen-
sate for a point mutation within the C-terminal rod.
The Four-Amino-Acid Region Is Required for MHC
Function in Early Muscle Development
To define the functional deficit of the constructs that do not
support viability, we analyzed the broods from heterozy-
Figure 2. C-terminal rod residues, but not the tailpiece, are con-
served in striated muscle myosins. The C-terminal sequences from
a diverse array of striated muscle myosins selected from the public
database (invertebrate striated, fish and rat skeletal, human and
chicken cardiac) are aligned at the beginning of rod zone 40
(McLachlan and Karn, 1982). The essential MHC A region defined
by constructs 30 and 34 (horizontal bar) contains conserved
charged residues (arrows) that are likely to be coiled coil (paircoil
score p 1.0; Berger et al., 1995). Boxes indicate serine and threonine
residues that might be potential phosphorylation sites. The acces-
sion numbers are P12844, M61229, P24733, AAK73348, A24922,
A46762, and P29616.













unc-54; myo-3/eDf1; stExN Viable, motile 50 44% (25) 47% (38) 45% (30) 49% (23)
unc-54; myo-3; stExN Viable, motile 0 0 0 7% (5) 0
Dead, arrested 25 33% (19) 29% (23) 21% (14) 23% (11)
unc-54; eDf1; stExN Larval lethal 25 23% (13) 24% (19) 27% (18) 28% (14)
The phenotypes of transgenic progeny from heterozygous hermaphrodites [unc-54(0); myo-3(0)/eDf1; stExN] carrying arrays with robust
expression of a mutant construct (designated stExN) were scored and counted (see MATERIALS AND METHODS). The transgenic progeny
were identified by expression of the GFP cotransformation marker. The first column lists the three genotypes that should segregate in a 2:1:1
ratio in the progeny of the heterozygous parent. The second column describes the phenotypes associated with each genotype, and the
expected frequency of that phenotype in the brood if the myosin construct present in the parent cannot rescue an animal lacking endogenous
body-wall MHC. The three constructs that remove or replace both of the conserved basic residues within the KIRA sequence fail to rescue
double mutant animals. The PIRA construct, which contains a single amino acid change within the KIRA sequence, can rescue double mutant
animals, but fewer than half survive. Animals homozygous for the eDf1 balancer chromosome elongate normally but die as larvae. Similar
data were collected from: 34 array stEx129; BH34 arrays stEx111, stEx112, stEx114; BHtagPIRA array stEx203; and BHtagPIAA array
stEx202 (our unpublished data).
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gous animals to determine the terminal phenotype of the
transgenic double mutant animals (see MATERIALS AND
METHODS). Like the myo-3 mutants that lack MHC A,
animals expressing only 34 constructs arrest elongation at
the twofold stage of embryogenesis and die as misshapen L1
larvae (Table 1). These results suggest that small deletions in
the rod cause a severe deficit in early myosin function.
Double mutant animals expressing constructs with muta-
tions within the KIRA sequence that disrupt both conserved
basic residues show a similar terminal phenotype (Table 1).
However, some of the double mutant animals expressing
these constructs arrest between the two- and threefold
stages. The ability of these constructs to support elongation
beyond the twofold stage suggests that the presence of the
tailpiece residues can to a small degree ameliorate the elon-
gation defect associated with the 34 construct.
Disruption of the Four-Residue Region Delays the
Onset of Movement in Embryos
The Pat phenotype (paralyzed, arrested elongation at the
twofold stage) observed in animals expressing only 34 has
been associated with mutations that have a range of defects
in early movement (Williams and Waterston, 1994). To ex-
amine the movement of animals expressing only 34 myo-
sin, we used time-lapse videomicroscopy to view develop-
ing embryos from heterozygous hermaphrodites carrying
arrays selected for robust expression (see MATERIALS AND
METHODS). Embryos expressing any of the 34 constructs
alone showed delayed initiation of movement (Figure 3).
Whereas wild-type animals twitch at the 1.5-fold stage and
begin coordinated rolling at the twofold stage (Williams and
Waterston, 1994), all transgenic double mutant embryos ex-
hibited no movement during these early stages and arrested
elongation at the twofold stage.
Double mutant embryos expressing 34 constructs did
eventually move. In most 34 transgenic lines, the late
movements began as weak, isolated twitches that slowly
increased in frequency and strength, such that most animals
showed late (660–900 min), weak movement of the head and
tail, but did not roll. The BH34 array stEx120 produced the
strongest movement in double mutant animals. In this line,
some individuals eventually twitched vigorously and
showed clear attempts to roll. In all cases, however, the late
movement did not lead to further elongation, and therefore
did not change the terminal arrest phenotype (Figure 4).
Similar analysis of myo-3(0) mutants revealed that the move-
ment phenotype of embryos expressing only MHC B is
similar to that of embryos expressing 34 (Figure 3). Double
mutant animals that express no body-wall myosin show no
movement at any time, and have the Pat phenotype.
Animals expressing only MHC with an intact tailpiece
and mutations within the four-residue region (KIRA,
PIRA, PIAA) exhibited similar defects in motility. The ob-
served delay in the onset of twitching was not as great in
animals expressing these constructs compared with those
expressing only 34. However, the observed movement was
qualitatively similar: motility slowly progressed from
twitches to movements of the head and tail, but no rolling
occurred.
In contrast, animals expressing only 30, which lacks the
tailpiece, have a movement phenotype similar to control
lines expressing full-length MHC. Some variability in the
onset of twitching is apparent in any line expressing MHC
from extrachromosomal arrays compared with the lines ex-
pressing MHC from genomic loci (Figure 3). The second 30
Figure 3. Animals expressing
only MHC with alterations in the
C-terminal rod show delayed on-
set of movement during embry-
ogenesis. The black bars indicate
the window of time in which vid-
eotaped embryos of each geno-
type first twitched. The time line,
measured in minutes from first
cleavage, represents data from
Sulston et al. (1983). Our obser-
vations of each embryo began at
the 1.5-fold stage, which was
designated as 420 min (see MA-
TERIALS AND METHODS). For
the top four strains, which ex-
press MHC from genomic loci, N
represents the number of indi-
viduals scored. The bottom nine
strains express MHC only from
extrachromosomal arrays. For
rescuing arrays, N represents
only animals that elongated suc-
cessfully, thus excluding pre-
sumptive mosaic animals that
had intermediate phenotypes. In
cases where inviable transgenic
double mutants segregate from a
heterozygous strain, N represents the number of arrested individuals that expressed the coinjection marker and/or showed delayed
movement throughout the length of the body, confirming the expression of the transgene in the arrested animal.
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transgene (stEx149), as well as the chimera4.tag array,
showed a slightly wider range in the time at which move-
ment was first detected. In both these lines, a few animals
that did not twitch until reaching the twofold stage went on
to move well and elongate properly. Therefore, these viable
animals initiated movement later than some nonviable indi-
viduals that expressed only MHC with mutations within the
KIRA residues. Thus, movement before the twofold stage is
apparently not essential for proper morphogenesis or via-
bility. In addition, these data indicate that lethality is not
caused by a simple delay in the onset of contractions. In-
stead, developmental arrest is associated with defects in
both the onset of twitching and the subsequent progression
to coordinated movement.
To assess the possible effects of gene dosage on early
movement, we videotaped embryos where myosin levels
were altered by genomic mutation or by transgene expres-
sion (Figure 3). Animals heterozygous for myo-3(0), which
have reduced MHC A, as well as unc-54(0) homozygotes,
which express no MHC B, showed little or no delay in the
onset of movement compared with wild type. Double mu-
tant animals that express full-length MHC A from trans-
genic arrays showed a small variation in onset of movement.
Because the onset of twitching and progression to coordi-
nated movement are not dramatically changed by variations
in the level of full-length myosin, the delayed movement
and subsequent lethality associated with constructs that
have mutations in the C-terminal rod cannot be explained by
a simple deficit in myosin expression.
Defects in Early Localization of 34 Protein
To elucidate the defect in 34 that leads to poor movement
and lethality, we used immunocytochemistry to examine the
localization of truncated proteins in developing embryos.
Antibody staining of homozygous myo-3 lines rescued by
34 revealed delayed localization of the truncated protein
into discrete bands. At the 1.5-fold stage, when movement
normally begins, the 34 protein did not exhibit the pattern
of strong bands evident in wild type and in controls (Figure
5). Instead, the protein localized weakly to bands, with
much stain remaining diffuse in the cytoplasm. Animals
expressing reduced or increased levels of full-length myosin
do not show this phenotype (Figure 5). Thus, in the absence
of full-length MHC A, the truncated myosin appears to
assemble more slowly. However, these rescued animals,
which contain endogenous MHC B, elongate normally and
survive.
To control for the possibility that the apparent delay in
localization of the truncated protein was a result of errors in
staging or an imbalance in myosin expression, we examined
the localization of the truncated protein in animals express-
ing endogenous MHC A but no MHC B. In this background,
we could directly compare the localization of full-length
MHC A and truncated MHC in the same muscle cells (Fig-
ure 6). BHtag30 protein colocalizes with endogenous MHC
A at all stages, and its early localization appears wild type.
In contrast, BHtag34 myosin shows a delay in localization
compared with MHC A during early stages of embryogen-
esis, similar to the delay seen with the 34 construct in the
myo-3 mutant (Figure 5). Thus, the presence of full-length
MHC A protein does not discernibly improve the movement
of 34 protein into A-bands. Conversely, we did not detect
any dominant-negative effect of the truncated protein dis-
rupting the assembly of wild-type MHC A. These data argue
that an intact rod is required at the level of the individual
molecule for proper protein localization in early stages of
muscle assembly. However, the tailpiece does not play a
detectable role in early protein localization.
To determine the behavior of 34 protein in the double
mutant background, where absence of the tailpiece and four
rod residues results in lethality and a long delay in the onset
of contractile function, we examined the localization of
BHtag34 protein in embryos by using isoform-specific an-
tibodies (Figure 7). The staining pattern observed is very
similar to that seen in the single mutants. Again, truncated
protein showed a delay in localization into discrete bands
compared with 30 constructs and a full-length control. The
localization of BHtag34 protein in the double mutants im-
proves over time, even following the failure in elongation,
such that the normal number of stained bands across the
quadrant is apparent in some regions of older arrested ani-
mals. These results suggest that the C-terminal rod residues
absent in 34 are required for timely localization but that
sequences within the remainder of the myosin molecule also
contribute to protein localization, although their action is not
sufficient to support viability.
Figure 4. Late movement in animals expressing only 34 does not
produce further elongation. (A) Nomarski micrograph of larvae
from the BHtag34-expressing strain unc-54(e190); myo-3(st386)/
eDf1; stEx120 after time-lapse video recording (see MATERIALS
AND METHODS). Five larvae that arrested elongation at the two-
fold stage (arrowheads) are flanked by their siblings that elongated
normally. Arrows point to the tips of the head and tail in one Pat
larva. (B) GFP coinjection marker indicates the presence of the
transgene in some of the Pat larvae.
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Animals expressing only MHC that contains mutations in
the four-residue region of the rod but has an intact tailpiece
domain have a terminal phenotype similar to those express-
ing only 34 (Table 1), but have less severe defects in early
movement (Figure 3). In antibody-staining experiments we
did not find a convincing delay in the localization of these
proteins into bands compared with endogenous MHC A
within the same cell (our unpublished data). Therefore, un-
like the 34 proteins, the functional deficit associated with
mutations that alter only residues within the four-residue-
region of the C-terminal rod cannot be consistently detected
at the level of the light microscope. Nonetheless, these pro-
teins are unable to support the timely initiation and progres-
sion of motility required for proper development.
Defective Localization of 30 Protein in Later
Stages of Embryogenesis
Although 30 protein shows no apparent delay in localization
during early stages of embryogenesis (Figures 5 and 6), all lines
expressing 30 showed a variably penetrant defect in localization
in later stages. In these lines, some embryos at the twofold stage or
later contained regions where myosin staining had broadened
such that the banded pattern that was apparent at earlier stages
was no longer visible (Figures 6, F and I, and 7, I and J). The
abnormally localized myosin appeared either as an inward exten-
sion of the membrane-associated contractile apparatus, or as a
relatively discrete round accumulation. In lines that express both
30 and full-length MHC A, the endogenous protein also ap-
peared in regions of expanded stain (Figure 6). Thus, molecules
lacking only the tailpiece seem to influence the localization of
full-length molecules. These observations suggest that30 protein
may be defective in a function required at the level of the filament
during later events in sarcomere formation or maintenance.
Tailpiece Residues Are Not Required for Proper
Filament Morphology
Animals expressing only 30, which lacks the tailpiece,
show no delay in early myosin localization or the onset of
Figure 5. 34 protein shows de-
layed localization into discrete
bands during early stages of mus-
cle cell organization. Each column
shows embryos from a given
strain. Each row depicts a different
developmental stage: 1.5-fold (A–
D), twofold (E–H), or threefold (I–
L). The staining pattern in unc-
54(e190) is similar to that in wild-
type, despite the lack of MHC B
and the resultant reduction in total
myosin. The third column shows
full-length MHC A that is overex-
pressed from a transgene in myo-3;
stEx80 animals (array chosen for
robust rescue; see MATERIALS
AND METHODS). Increased
MHC A results in stray filamen-
tous staining (arrowhead in G)
and occasional aberrant expansion
of stain within or near the contrac-
tile apparatus (K). However,
strong bands of stain are evident
at the 1.5-fold stage (C). Distribu-
tion of 34 protein in myo-3;
stEx129 animals is distinct, with
diffuse stain outlining the nuclei
(D and H). Occasional abnormal
round accumulations that are
found within the muscle cell body
(L) may be due to inappropriate
levels of MHC accumulation. An-
imals are stained with MHC A-
specific antibody (5–6), which rec-
ognizes endogenous protein in
wild-type and unc-54 mutants,
and transgenic protein in the re-
maining genotypes. In wild type,
four muscle quadrants run longi-
tudinally along the length of the animal. In most areas, four longitudinal bands of stain are apparent across the width of a single muscle
quadrant (between the arrowheads in I). The stages refer to the length of the elongating animal compared with the surrounding eggshell: at
1.5-fold, the posterior tip (arrowhead in A) has reached half the length of the egg as it elongates and moves toward the anterior end (arrow),
positioned at the opposite pole of the egg. Bar, 5 m. Myosin localization during embryogenesis has been described previously (Epstein et
al., 1993; Hresko et al., 1994; Williams and Waterston, 1994).
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muscle contraction. These observations suggest that the tail-
piece does not play an important role in the assembly of
myosin into filaments. To test this hypothesis further, we
examined the ability of 30 protein to show the MHC A-
specific localization to the central portion of the myosin-
containing A-bands of the contractile apparatus. To obtain a
level of total myosin expression close to that of wild type, a
30 array selected for poor rescue of unc-54 (which lacks the
major myosin, MHC B) was crossed into the myo-3 back-
ground, which lacks MHC A but expresses wild-type levels of
endogenous MHC B. In these animals the isoform-specific
staining pattern, as well as overall organization of the contrac-
tile apparatus, appeared wild-type (Figure 8). These data argue
that the MHC A tailpiece sequences are not required for proper
localization of the MHC A isoform within the filament, or for
proper placement of filaments within the sarcomere.
To determine whether loss of tailpiece residues affects fila-
ment morphology, we examined cross sections of adult ani-
mals by transmission electron microscopy (TEM). Most fila-
ments in animals expressing only 30 seemed normal in
diameter and orientation, but were poorly organized (Figure 9,
C and D). Defects in organization varied, even between muscle
cells within the same animal. Common abnormalities included
large clusters of filaments that had no apparent division into
individual sarcomeres, and groups of filaments displaced in-
teriorly from the membrane. Occasionally abnormal assem-
blages of filaments were seen, but the majority of filaments
appeared normal in cross section. These observations suggest
that the tailpiece residues are not required for proper filament
structure but may be required at the level of the filament for
establishment or maintenance of sarcomere structure.
We were unable to do a similar TEM analysis of the
morphology of filaments containing only 34 because these
animals arrest during embryogenesis. However, we did ex-
amine muscle in which BH34 replaced the essential iso-
form, MHC A. In these animals, thick filament morphology
appeared wild type, and only relatively minor defects in
filament organization were apparent (Figure 9B). Therefore,
Figure 6. Comparison of the distribution of full-length and truncated proteins within the same muscle cells at three developmental stages
(A–C, 1.5-fold; D–F, twofold; and G–I, threefold) shows delayed localization of 34, but not 30 constructs. Strains in which a truncated or
chimeric construct rescues the unc-54(0) mutation were stained with antibody 5–14 (which recognizes an epitope in the MHC A head) to
visualize endogenous MHC A. All transgenic proteins, which contain the tagged MHC B head, were detected using anti-HA antibody. In
early stages, BHtag34 staining is strong outside the contractile apparatus (arrowheads A and D) compared with MHC A (A and D). Insets
show staining in the perinuclear region. The chimera4.tag staining colocalizes with that of MHC A at all stages (B, E, and H), demonstrating
that the HA tag, and the MHC B head and tailpiece sequences do not discernibly alter localization. The BHtag30 protein localizes normally
at 1.5-fold (C). Later, embryos expressing 30 constructs often show areas in which staining of 30 and MHC A are abnormally expanded
within or near the plane of the contractile apparatus (arrows in F, F, I, I). Transgenic arrays shown are stEx120, stEx118, and stEx154. Bar,
5 m.
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the delayed localization of 34 constructs does not have
dramatic effects on final filament or sarcomere structure in
animals that also express full-length MHC B.
DISCUSSION
An Intact Rod Is Required for Proper Assembly
Our experiments using C-terminally truncated myosin con-
structs have defined a four amino-acid region at the C ter-
minus of the MHC A rod that is essential for viability (Figure
1). The observation that a small deletion within the coiled
coil causes a marked disruption of early myosin function
suggests that these residues are critical for early events in
filament formation (Figure 3 and Table 1). The abnormal
persistence of diffuse 34 protein (which lacks the tailpiece
and four residues of coiled coil) during early muscle devel-
opment suggests that loss of these rod residues delays
proper localization and assembly into filamentous structures
(Figures 5–7). The presence of 34 MHC did not disrupt the
localization pattern of endogenous MHC within the same
muscle cell. Therefore, loss of these rod residues seems to
delay the organization of individual molecules but does not
lead to dominant-negative effects, such as the initiation of
ectopic structures, that incorporate full-length MHC.
Although the four terminal residues of the coiled coil are
essential for viability, removal of these residues clearly re-
sults in a molecule that has only partial loss of function. The
34 constructs, which lack these residues, are able to rescue
mutants that lack either single MHC isoform. Animals in
which 34 replaces MHC A, the essential isoform, can have
near-normal muscle cell organization and contain thick fil-
aments of normal morphology (Figure 9). Therefore, in the
presence of full-length MHC B, the four residues of MHC A
coiled coil are not required for proper filament initiation or
Figure 7. Localization of 30 and
34 proteins is distinct at early de-
velopmental stages in animals ex-
pressing only truncated MHC.
Three stages of embryogenesis are
represented: A–D, 1.5-fold; E–H,
twofold; and I–L, threefold. Like
wild-type, embryos expressing
only a 30 construct have well-
defined stripes of myosin staining
at the 1.5-fold stage (arrowheads
in A and B), the time at which
movement commences in wild
type. A full-length chimeric pro-
tein expressed in the double mu-
tant shows the same pattern (D).
Later in development, animals ex-
pressing only 30 often show re-
gions of expanded stain, indicat-
ing aberrant accumulations of 30
MHC within or near the contrac-
tile apparatus (arrows in F, I, and
J). Expression of a single full-
length construct can also result in
abnormal, irregularly shaped ac-
cumulations (L, arrow) or stray fil-
amentous staining (L, arrowhead)
in later developmental stages. In
contrast, a 34 construct in double
mutant animals shows delayed lo-
calization of the protein in early
stages of muscle cell organization.
At the 1.5-fold stage, embryos ex-
pressing only BHtag34 have no
prominent bands (C). Instead,
staining appears dotted or broken
(arrowhead), and diffuse staining
outside the contractile apparatus
is strong. These animals arrest
elongation at the twofold stage,
but the localization of truncated myosin changes as development continues. In younger arrested animals (G), the bands of staining grow
stronger compared with diffuse staining in the cell body. Older arrested animals (K) show strong localization of the protein to bands, in some
places showing the four bands per quadrant characteristic of wild type (arrowheads), despite the aberrant shape of the animals. 30
expressed from transgene stEx148 was stained with antibody 5.6. The three tagged constructs, BHtag30 stEx153, BHtag34 stEx120, and
chimera4.tag stEx118, were stained with anti-HA. The transgenic double mutant embryos from the strain unc-54(e190); myo-3(st386)/eDf1;
stEx120 were recognized by their failure to stain with the MHC A head-specific antibody 5–14. Bar, 5 m.
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filament structure. Although animals expressing only 34
did not commence embryonic movement at the correct time,
movement did eventually occur, as did the late localization
of the truncated protein to filamentous structures. The mo-
tility phenotype and antibody staining results are consistent
with the hypothesis that the 34 protein eventually forms
functional filaments. Although we cannot rule out the pos-
sibility that filaments containing only 34 are abnormal, the
tools required to examine the appropriate developing em-
bryos at the ultrastructural level do not currently exist.
Comparison of the C. elegans MHC A sequence to other
striated muscle myosins in the public databases revealed
that two basic amino acids within the four-residue region
are conserved in both vertebrate and invertebrate MHCs
(Figure 2). Mutant constructs in which these basic residues
are altered or deleted behave genetically like 34 (Figure 1
and Table 1). That is, these proteins have sufficient activity to
rescue single mutant animals but do not support viability of
double mutant animals that lack endogenous MHC. Al-
though the precise manner in which loss of these charged
residues within the rod affects myosin function is unknown,
previous studies have shown that small perturbations in
charge can have profound effects on assembly in vivo
(Gengyo-Ando and Kagawa, 1991; Nock et al., 2000). There-
fore, the functional defect may result directly from loss of
two highly conserved charged residues that play a key role
in the intermolecular interactions involved in driving fila-
ment assembly or specifying filament structure.
A number of studies in various systems point to the
importance of the C-terminal rod in myosin assembly. In
vertebrate striated muscle myosin, a 29-residue region of the
coiled coil near the C terminus of the rod, the assembly-
competent domain (ACD), has been proposed to be essential
for ordered assembly of rod fragments in vitro and of trun-
cated myosin expressed in COS cells (Sohn et al., 1997). Our
studies did not alter or remove any residues within the
ACD, so the role of the ACD in C. elegans has not yet been
tested. Sohn et al. (1997) tested C-terminally truncated con-
structs in which the four-residue region defined in our study
was removed and found no effect on assembly competence
in vitro or in cell lines. Their observations are consistent with
our data, which indicate that loss of the four terminal resi-
dues of coiled coil causes a partial loss of assembly function.
Our genetic and antibody staining experiments were able to
detect a delay in the assembly of the 34 protein because of
the lethal consequences of delayed assembly in vivo and our
ability to compare the localization of truncated protein to
Figure 8. Isoform-specific localization does not require the tail-
piece. Adults in which relatively low levels of 30 expression re-
place endogenous MHC A [myo-3(st386); stEx150] were stained with
directly labeled isoform-specific antibodies. Isoform-specific local-
ization and overall cell structure are normal, as viewed in this
portion of a muscle quadrant in which parts of three cells are visible.
The left side of the micrograph shows MHC B staining along the
outside edges of each A-band, and the central stripe of MHC A is
shown on the right (compare with Miller et al., 1983). Bar, 5 m.
Figure 9. Thick filaments containing truncated protein have nor-
mal morphology by TEM analysis. (A) In wild-type adults, thick
filaments (viewed in cross section, arrowhead) are organized
around the M-line structure (m) within the contractile apparatus.
An area of thin filaments devoid of thick filaments surrounds the
dense body (db), which anchors thin filaments. The contractile
apparatus is attached to the muscle cell membrane that is adjacent
to the hypodermis, which secretes the outer cuticle. (B) Animals
[myo-3(st386); stEx114] in which an array with robust expression of
BH34 replaces MHC A (the essential minor isoform) contain well-
organized, normal thick filaments despite the increased level of total
myosin, and the presence of the truncated myosin that exhibits
delayed localization. Some ectopic filaments are found above the
dense bodies (arrowheads). Given the structure of obliquely striated
muscle (Waterston, 1988), these are likely to be filaments from an
adjacent sarcomere that are abnormally long. (C and D) In animals
expressing only 30 [unc-54(e190); myo-3(st386); stEx148], most thick
filaments are uniform and normal in appearance, but are poorly
organized. (C) Some thick filaments are found associated with M-
line structures, but are unevenly and loosely packed with respect to
each other. Some filaments are located at a more interior position,
apparently not attached to the membrane (arrowheads). These stray
filaments overlie two dense bodies that have no A-band between
them. (D) In some areas there appear to be tangles of filaments that
are not oriented on the long axis of the cell. Bar, 200 nm.
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that of endogenous MHC A within the same muscle cell at
different developmental stages.
MHC A-specific Function
Our current experiments confirm that the essential MHC
A-specific activity is limited to the rod sequences. A chi-
meric molecule that contains only the MHC A rod has
sufficient activity to rescue double mutant animals express-
ing no endogenous MHC (Figure 1). However, the observa-
tion that the 34 construct is able to provide MHC A-specific
function in the single myo-3(0) mutant demonstrates that the
presence of full-length MHC B allows viability when the
only MHC A present has partial function. In a previous
study, two regions of the MHC A rod sufficient for the
essential MHC A-specific function were mapped by testing
chimeric myosins in the myo-3(0) single-mutant background
(Hoppe and Waterston, 1996). Our current results raise the
possibility that the regions defined previously are important
for MHC A isoform-specific function but may not have
sufficient activity to support viability in the double-mutant
background. Consistent with this possibility, studies of the
MHC A-specific interaction with paramyosin led to the pro-
posal that sequences along the length of the rod contribute
to isoform-specific activity (Hoppe and Waterston, 2000).
The Tailpiece Domain Is Not Required for Filament
Formation
In contrast to the effects of small deletions in the coiled coil,
removal of the tailpiece alone does not discernibly alter early
myosin function in animals that do not express full-length
MHC in the body-wall muscle. Early myosin localization (Fig-
ures 5–7) and the onset of contraction (Figure 3) seem normal
in animals expressing only 30 myosin, which lacks the tail-
piece domain. In addition, tailpiece sequences are not required
for isoform-specific localization within the thick filament (Fig-
ure 8) or for normal filament morphology (Figure 9). Because
alterations within the adjacent rod region produce a dramatic
defect in early myosin function in vivo, we believe it is unlikely
that our failure to detect similar defects in the 30 protein is
due to a lack of sensitivity in our assays. Instead, our data
suggest that the two adjacent domains, the rod and the tail-
piece, are required for distinct steps during muscle develop-
ment in vivo. A very similar conclusion was reached in the in
vitro analysis of proteolytically cleaved Acanthamoeba myosin II
(Sathyamoorthy et al., 1990).
The ability of MHC A lacking the tailpiece (30) to localize
correctly and support the timely onset of contractile function
suggests that the tailpiece residues do not play an important
role in promoting assembly of the filament per se. Therefore,
our data do not support a model in which tailpiece sequences
in C. elegans striated muscle act to drive filament assembly or
specify filament structure, as has been proposed for the tail-
piece in Acanthamoeba myosin II (Sinard et al., 1989) and for
smooth muscle MHC (Rovner et al., 2002). Our results are
consistent with the observation that the assembly of Drosophila
MHC into thick filaments of the distinct morphologies found in
different skeletal muscle cell types is not dependent upon the
identity of the tailpiece residues (Wells et al., 1996).
Our failure to detect defects in 30 localization also suggests
that the tailpiece is unlikely to play an important role in regu-
lating assembly of MHC into filaments. In smooth muscle,
phosphorylation of tailpiece residues has been associated with
the formation of a folded, assembly-incompetent form of the
MHC molecule. Similarly, phosphorylation within the tailpiece
domain can reduce assembly of nonmuscle MHCs in vitro
(Murakami et al., 1998). If the tailpiece played a similar inhib-
itory role in C. elegans, we might expect loss of the tailpiece
domain to lead to premature assembly of MHC into ectopic or
otherwise aberrant structures. Instead, myosin stain in em-
bryos expressing only 30 appears normal during early stages
of muscle development (Figure 7). Furthermore, the 30 MHC
A protein shows the appropriate isoform-specific staining pat-
tern within the A-band in adult muscle cells (Figure 8). There-
fore, our data do not support a model in which the C. elegans
body-wall MHC tailpiece regulates the assembly competence
of the individual molecule.
Possible Roles for the Tailpiece Residues
Our experiments with truncated MHC do not support a require-
ment for the tailpiece in early events of thick filament formation.
Furthermore, because animals in which truncated MHC A (30)
replaces endogenous MHC A have normal isoform-specific local-
ization and wild-type cellular organization (Figure 8), we can
conclude that the tailpiece need not be present throughout the
filament, nor in the filament center where initiation is thought to
occur, for normal sarcomere patterning and maintenance. There-
fore, our data suggest that any requirement for the tailpiece may
be at the level of the individual filament rather than at the level of
the single molecule.
Antibody staining experiments reveal that animals express-
ing truncated myosin lacking tailpiece residues (30) exhibit
defects in myosin localization in later embryogenesis (Figures 6
and 7). Therefore, it is possible that the tailpiece is required for
the establishment or maintenance of filament position within
the contractile apparatus. Two observations suggest that loss of
the tailpiece may affect maintenance of sarcomere structure,
rather than specification of its pattern. First, initial localization
of 30 during embryogenesis appears normal, and the appear-
ance of disordered myosin stain occurs when the embryo is
actively moving. Second, electron microscopy (Figure 9) re-
veals that animals expressing only 30 contain filaments that
are located internally in the cell, rather than being attached to
the membrane adjacent to the hypodermis. Because the pat-
terning of the contractile apparatus in C. elegans is thought to
occur at this membrane (Hresko et al., 1994; Williams and
Waterston, 1994), the ectopic filaments may have been dis-
placed from their initial location. In Drosophila, loss of sarco-
mere structure upon contraction has been demonstrated in
animals expressing an embryonic MHC isoform in adult flight
muscle (Wells et al., 1996).
Two possible models for tailpiece function are suggested by
the apparent loss of sarcomere structure after the onset of
contractile activity. First, the tailpiece may mediate proper
attachment to, or stabilization of, the M-line, which anchors
thick filaments. Second, the tailpiece domain may be required
for appropriate regulation of the contractile activity of the
filament. A similar role has been proposed for the tailpiece of
Acanthamoeba myosin II (Ganguly et al., 1990). Consistent with
this possibility, mutations in C. elegans twitchin (encoded by
unc-22) that disrupt contractile regulation lead to defects in
sarcomere structure (Moerman et al., 1988; Benian et al., 1989).
Although the tailpiece does not play an essential role in
early muscle development, our data suggest that the domain
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does affect the activity of myosin molecules during early
stages. The early movement and terminal arrest phenotypes
are more severe in animals expressing only 34 (which lacks
the tailpiece and four rod residues) than in animals express-
ing only constructs that have mutations within the C-termi-
nal rod and an intact tailpiece domain. The ability of the
tailpiece to improve motility and embryonic elongation sug-
gests that the presence of the tailpiece domain contributes to
early myosin function. There are three plausible mecha-
nisms by which tailpiece sequences may be acting during
these stages: 1) the domain may directly contribute to early
localization of the molecule, although this role is not essen-
tial or detectable in our studies of 30 protein; 2) the pres-
ence of the tailpiece may stabilize the coiled coil at the C
terminus of the rod, which plays a key role in localization
and assembly; and 3) the tailpiece contributes to some other
early function, such as filament placement or contractile
activity. Because our genetic and antibody staining experi-
ments have proven to be sensitive (discussed above), our
data favor the latter two models. However, further studies
are required to elucidate tailpiece function in C. elegans.
Because the organization of the contractile apparatus is not
completely wild type in any strain expressing a single full-
length MHC construct (our unpublished observations),
these experiments must involve different approaches to test
the possible role of the tailpiece in filament organization.
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